238 related articles for article (PubMed ID: 17166655)
1. Cellular response to etoposide treatment.
Montecucco A; Biamonti G
Cancer Lett; 2007 Jul; 252(1):9-18. PubMed ID: 17166655
[TBL] [Abstract][Full Text] [Related]
2. Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesions.
Scovassi AL; Pellegata NS; Di Stefano L; Padovan L; Negri C; Prosperi E; Riva F; Ciomei M; Ranzani GN
Anticancer Res; 2001; 21(4A):2803-8. PubMed ID: 11724358
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Bowman KJ; Newell DR; Calvert AH; Curtin NJ
Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
[TBL] [Abstract][Full Text] [Related]
4. Multilevel therapeutic targeting by topoisomerase inhibitors.
Smith PJ; Souès S
Br J Cancer Suppl; 1994 Sep; 23():S47-51. PubMed ID: 8075006
[TBL] [Abstract][Full Text] [Related]
5. Concentration-dependent variable effects of etoposide on the cell cycle of CML cells.
Fukumi S; Horiguchi-Yamada J; Iwase S; Ohno T; Yamada H
Anticancer Res; 2000; 20(5A):3105-10. PubMed ID: 11062729
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis is the most efficient death-pathway in tumor cells after topoisomerase II inhibition.
El-Awady RA; Ali MM; Saleh EM; Ghaleb FM
Saudi Med J; 2008 Apr; 29(4):558-64. PubMed ID: 18382799
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis.
Beere HM; Chresta CM; Alejo-Herberg A; Skladanowski A; Dive C; Larsen AK; Hickman JA
Mol Pharmacol; 1995 May; 47(5):986-96. PubMed ID: 7746285
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity.
Langer SW; Schmidt G; Sørensen M; Sehested M; Jensen PB
Clin Cancer Res; 1999 Oct; 5(10):2899-907. PubMed ID: 10537359
[TBL] [Abstract][Full Text] [Related]
9. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
10. Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide.
Facompré M; Wattez N; Kluza J; Lansiaux A; Bailly C
Mol Cell Biol Res Commun; 2000 Jul; 4(1):37-42. PubMed ID: 11152626
[TBL] [Abstract][Full Text] [Related]
11. [Cytotoxic mechanism and antineoplastic action of etoposide].
Dołega A
Postepy Hig Med Dosw; 1998; 52(1):67-87. PubMed ID: 9608232
[TBL] [Abstract][Full Text] [Related]
12. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.
Potter AJ; Rabinovitch PS
Mutat Res; 2005 May; 572(1-2):27-44. PubMed ID: 15790488
[TBL] [Abstract][Full Text] [Related]
13. BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II.
Treszezamsky AD; Kachnic LA; Feng Z; Zhang J; Tokadjian C; Powell SN
Cancer Res; 2007 Aug; 67(15):7078-81. PubMed ID: 17671173
[TBL] [Abstract][Full Text] [Related]
14. DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide.
Giocanti N; Hennequin C; Balosso J; Mahler M; Favaudon V
Cancer Res; 1993 May; 53(9):2105-11. PubMed ID: 8386982
[TBL] [Abstract][Full Text] [Related]
15. Altered formation of DNA in human cells treated with inhibitors of DNA topoisomerase II (etoposide and teniposide).
Lönn U; Lönn S; Nylen U; Winblad G
Cancer Res; 1989 Nov; 49(22):6202-7. PubMed ID: 2553248
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine.
Dassonneville L; Bonjean K; De Pauw-Gillet MC; Colson P; Houssier C; Quetin-Leclercq J; Angenot L; Bailly C
Biochemistry; 1999 Jun; 38(24):7719-26. PubMed ID: 10387011
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of bengacarboline derivatives.
Pouilhès A; Kouklovsky C; Langlois Y; Baltaze JP; Vispé S; Annereau JP; Barret JM; Kruczynski A; Bailly C
Bioorg Med Chem Lett; 2008 Feb; 18(3):1212-6. PubMed ID: 18083028
[TBL] [Abstract][Full Text] [Related]
18. Experimental induction of apoptosis by a combination of etoposide and radiation treatment.
Toda H; Hasegawa M; Hayakawa K; Kawashima M; Nakamura Y; Yamakawa M; Mitsuhashi N; Niibe H
Anticancer Res; 2000; 20(1A):165-70. PubMed ID: 10769650
[TBL] [Abstract][Full Text] [Related]
19. Antitumor agents. Part 230: C4'-esters of GL-331 as cytotoxic agents and DNA topoisomerase II inhibitors.
Han S; Xiao Z; Bastow KF; Lee KH
Bioorg Med Chem Lett; 2004 Jun; 14(11):2979-82. PubMed ID: 15125972
[TBL] [Abstract][Full Text] [Related]
20. From DNA damage to G2 arrest: the many roles of topoisomerase II.
Larsen AK; Escargueil AE; Skladanowski A
Prog Cell Cycle Res; 2003; 5():295-300. PubMed ID: 14593724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
